FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient Centric Drug Development Second Edition

Prix à partir de
48,90

En vedette

COMPARER TOUS LES MAGASINS EN LIGNE (2)

Description

Amazon FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition
Description Description
Product Specifications Spécifications du produit
Résultats connexes Résultats connexes
Next
Previous

Comparer les boutiques en ligne (2)

Shop
Prix
Affranchissement
Prix total
Amazon Logo
48,90 €
Gratuit
48,90 €
Voir l’offre
Gratuit Shipping Costs
Amazon Marketplace Logo
48,90 €
Gratuit
48,90 €
Voir l’offre
Gratuit Shipping Costs
Description (1)

FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition

Spécifications du produit

Marque LAP LAMBERT Academic Publishing
EAN
  • 9786209608780

LAP LAMBERT Academic Publishing

Visual & Clinical Outcome in Patients with Corneal Laceration: Second Edition

60,90 €
Comparer 2 magasins 2 magasins

ThinkPlus Pharma Publications

Essentials of Clinical Trials and Cancer Drug Development

16,26 €
Comparer 2 magasins 2 magasins

LAP LAMBERT Academic Publishing

Application of DFE and DFMA for enabling sustainable development: Exclusively automotive sectors Second Edition

79,15 €
Comparer 2 magasins 2 magasins

Aurea Flores Consultants, LLC

An Insider's View of Clinical Trials and Drug Development

33,06 €
Comparer 2 magasins 2 magasins
Choix en vedette
48,90 €
Voir l’offre